Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures

John Crawford^{1

2}, Jeffrey Gold^{1

2}, Richard Haas^{1

2}

Affiliations

¹ Department of Neurosciences and Pediatrics, University of California, San Diego, San Diego.
² Rady Children's Hospital-San Diego, San Diego, California.

Comment

John Crawford et al. JAMA Neurol. 2022.

. 2022 Jan 1;79(1):90-91.

doi: 10.1001/jamaneurol.2021.4109.

John Crawford^{1

2}, Jeffrey Gold^{1

2}, Richard Haas^{1

2}

¹ Department of Neurosciences and Pediatrics, University of California, San Diego, San Diego.
² Rady Children's Hospital-San Diego, San Diego, California.

No abstract available

Comment in

Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures-Reply.
Glass HC, Shellhaas RA. Glass HC, et al. JAMA Neurol. 2022 Jan 1;79(1):91-92. doi: 10.1001/jamaneurol.2021.4112. JAMA Neurol. 2022. PMID: 34779827 No abstract available.

Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures.
Glass HC, Soul JS, Chang T, Wusthoff CJ, Chu CJ, Massey SL, Abend NS, Lemmon M, Thomas C, Numis AL, Guillet R, Sturza J, McNamara NA, Rogers EE, Franck LS, McCulloch CE, Shellhaas RA. Glass HC, et al. JAMA Neurol. 2021 Jul 1;78(7):817-825. doi: 10.1001/jamaneurol.2021.1437. JAMA Neurol. 2021. PMID: 34028496 Free PMC article.